These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 6685516

  • 1. [Clinical comparative trial of piretanide and furosemide in patients with advanced renal insufficiency. Drug levels and diuretic potency of single oral doses].
    Heuer LJ, Machnik H, Studt J, Fink R.
    Arzneimittelforschung; 1983; 33(9):1318-21. PubMed ID: 6685516
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of reduced effects of loop diuretics in healthy volunteers and in patients with renal disease.
    Sjöström P.
    Scand J Urol Nephrol Suppl; 1988; 111():1-66. PubMed ID: 3201162
    [Abstract] [Full Text] [Related]

  • 3. Oral piretanide in chronic renal failure.
    Henderson IS, Beattie TJ, Kennedy AC, Dombey SL.
    Br J Clin Pharmacol; 1982 Dec; 14(6):857-60. PubMed ID: 7150461
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the short-term effects of the loop diuretic piretanide and furosemide in patients with renal insufficiency.
    Marone C, Reubi FC, Lahn W.
    Eur J Clin Pharmacol; 1984 Dec; 26(4):413-8. PubMed ID: 6734705
    [Abstract] [Full Text] [Related]

  • 5. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
    Sagar S, Sharma BK, Sharma PL, Wahi PL.
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378
    [Abstract] [Full Text] [Related]

  • 6. Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Clissold SP, Brogden RN.
    Drugs; 1985 Jun; 29(6):489-530. PubMed ID: 3891305
    [Abstract] [Full Text] [Related]

  • 7. Clinical pharmacology of loop diuretics: a comparative study.
    Ansuini R, Pulido M, Pupita G, Gaggi S, Pupita F.
    Int J Clin Pharmacol Res; 1985 Jun; 5(2):113-21. PubMed ID: 4018941
    [Abstract] [Full Text] [Related]

  • 8. Renal responses and pharmacokinetics of piretanide in humans: effect of route of administration, state of hydration and probenecid pretreatment.
    Noormohamed FH, McNabb WR, Dixey JJ, Lant AF.
    J Pharmacol Exp Ther; 1990 Sep; 254(3):992-9. PubMed ID: 2395126
    [Abstract] [Full Text] [Related]

  • 9. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S, Annigeri RA, Seshadri R, Rao BS, Prakash KC, Mani MK.
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [Abstract] [Full Text] [Related]

  • 10. Renal tubular secretion of piretanide and its effects on electrolyte reabsorption and tubuloglomerular feedback mechanism.
    Odlind B, Beermann B, Selén G, Persson AE.
    J Pharmacol Exp Ther; 1983 Jun; 225(3):742-6. PubMed ID: 6864530
    [Abstract] [Full Text] [Related]

  • 11. Effect of furosemide oral solution versus furosemide tablets on diuresis and electrolytes in patients with moderate congestive heart failure.
    Cohen N, Golik A, Dishi V, Zaidenstein R, Weissgarten J, Averbukh Z, Modai D.
    Miner Electrolyte Metab; 1996 Jun; 22(4):248-52. PubMed ID: 8807629
    [Abstract] [Full Text] [Related]

  • 12. Effects of a new diuretic (piretanide) compared with furosemide on renal diluting and concentrating mechanisms in patients with the nephrotic syndrome.
    Marone C, Reubi FC.
    Eur J Clin Pharmacol; 1980 Jun; 17(3):165-71. PubMed ID: 7363930
    [Abstract] [Full Text] [Related]

  • 13. Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.
    McNabb WR, Noormohamed FH, Lant AF.
    Br J Clin Pharmacol; 1988 Aug; 26(2):143-54. PubMed ID: 3207551
    [Abstract] [Full Text] [Related]

  • 14. [Bumetanide, a new diuretic active during chronic renal failure (author's transl)].
    Fries D, Beroniade V, Coy JL, Delavelle F.
    Pathol Biol (Paris); 1976 Jun; 24(6):435-9. PubMed ID: 785349
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function.
    Traeger A, Stein G, Sperschneider H, Keil E.
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):481-6. PubMed ID: 6500766
    [Abstract] [Full Text] [Related]

  • 16. A comparative diuretic and tissue distribution study of bumetanide and furosemide in the dog.
    Cohen MR, Hinsch E, Vergona R, Ryan J, Kolis SJ, Schwartz MA.
    J Pharmacol Exp Ther; 1976 Jun; 197(3):697-702. PubMed ID: 932999
    [Abstract] [Full Text] [Related]

  • 17. The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure.
    Verho M, Bückert C, Freude J, Jaeger S, Pahnke K.
    Pharmatherapeutica; 1985 Jun; 4(5):288-95. PubMed ID: 3906674
    [Abstract] [Full Text] [Related]

  • 18. Use of piretanide, a new loop diuretic, in cirrhosis with ascites: relationship between the diuretic response and the plasma aldosterone level.
    Arroyo V, Bosch J, Casamitjana R, Cabrera J, Rivera F, Rodés J.
    Gut; 1980 Oct; 21(10):855-9. PubMed ID: 7439805
    [Abstract] [Full Text] [Related]

  • 19. Comparison of azosemide and furosemide in ascitic patients without and during administration of spironolactone.
    Radó JP, Molnár Z, Hartai A, Gercsák G.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):532-7. PubMed ID: 7174156
    [Abstract] [Full Text] [Related]

  • 20. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.